Stock Split History
ETFs Holding URGN »    URGN Historical Stock Prices »
Video: What is a Stock Split?

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
UroGen Pharma is a biotechnology company focused on developing and commercializing solutions that treat urothelial and specialty cancers. Co. has developed RTGel® reverse-thermal hydrogel, a proprietary sustained release, hydrogel-based technology that has the potential to improve therapeutic profiles of existing drugs. Co.'s Jelmyto® (mitomycin) for pyelocalyceal solution, and its UGN-102 (mitomycin) for intravesical solution, are designed to ablate tumors by non-surgical means and to treat several forms of non-muscle invasive urothelial cancer, including low-grade upper tract urothelial cancer and low-grade intermediate risk non-muscle invasive bladder cancer, respectively. According to our UroGen Pharma stock split history records, UroGen Pharma has had 0 splits.
UroGen Pharma stock split history picture
UroGen Pharma (URGN) has 0 splits in our UroGen Pharma stock split history database.

Looking at the UroGen Pharma stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into UroGen Pharma shares, starting with a $10,000 purchase of URGN, presented on a split-history-adjusted basis factoring in the complete UroGen Pharma stock split history. UroGen Pharma split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 05/05/2017
End date: 09/22/2023
Start price/share: $14.00
End price/share: $15.69
Dividends collected/share: $0.00
Total return: 12.07%
Average Annual Total Return: 1.80%
Starting investment: $10,000.00
Ending investment: $11,206.75
Years: 6.39
Date Ratio
Neoleukin Therapeutics, Inc. (NLTX)
Sigma Additive Solutions, Inc. (SASI)
PolyPid Ltd. (PYPD)
SciSparc Ltd. (SPRC)
Antelope Enterprise Holdings Limited (AEHL)
Flotek Industries, Inc. (FTK)
Ascent Solar Technologies, Inc. (ASTI)
Super League Gaming, Inc. (SLGG)
IMAC Holdings, Inc. (BACK)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »
Funds Holding UroGen Pharma
UroGen Pharma Insider Buying

UroGen Pharma Stock Split History | | Copyright © 2013 - 2023, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
Wait! Don't leave yet.
Want to receive our latest research absolutely free?

Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.1%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.1%.